Inhibitory effects of Δ8-tetrahydrocannabinol on nicotine metabolism and implications as a smoking cessation agent
Drug Metabolism and Disposition · 2026
DOI: 10.1016/j.dmd.2026.100235 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2026. Verfasst von Mengqi Zhao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Biosciences, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buff…. Hauptthemen laut MEDLINE: Dronabinol, Nicotine, Cytochrome P-450 CYP2A6, Smoking Cessation Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cancer Institute, National Cancer Institute Division of Cancer Prevention.
Abstract (Originalsprache)
Tobacco use remains the leading cause of preventable death worldwide. The major metabolic pathway for nicotine, the addictive component in tobacco, is via cytochrome P450 (CYP) 2A6-mediated metabolism to cotinine. Cannabidiol has been shown to reduce cigarette consumption in vivo and inhibit CYP2A6-mediated nicotine metabolism in vitro. In the present study, Δ-8-tetrahydrocannabinol (Δ8-THC), an isomer of Δ-9-tetrahydrocannabinol, was examined as a potential inhibitor of CYP2A6-mediated nicotine metabolism. While Δ-9-tetrahydrocannabinol showed no significant inhibition of nicotine metabolism to cotinine, Δ8-THC demonstrated unbound IC 50 values of 0.57 ± 0.04 μ M in microsomes from recombinant wild-type CYP2A6 overexpressing human embryonic kidney 293 cells and 0.70 ± 0.16 μ M in human liver microsomes (HLMs). A similar unbound IC 50 value was observed for recombinant CYP2A6∗5 microsomes (0.52 ± 0.17 μ M) and was modestly elevated in recombinant CYP2A6∗2 microsomes (1.00 ± 0.12 μ M). IC 50 shift experiments were consistent across pooled HLM (5.3-fold) and microsomes from liver specimens exhibiting the CYP2A6 (∗2/∗2) and (∗9/∗9) genotypes (6.1- and 4.0-fold, respectively) but were reduced in CYP2A6 (∗35/∗35) microsomes (1.0-fold). Irreversible inhibition kinetics in pooled HLMs by Δ8-THC yielded a k i n a c t value of 0.022 ± 0.001 min -1 and an unbound K I value of 0.232 ± 0.062 μ M. Static modeling predicted that oral dosing with 10 mg Δ8-THC increased the nicotine plasma area under the curve by 189%, with further increases observed at 20 mg and 40 mg; interactions were also observed with inhalation doses ≥70 mg. These findings suggest that, based on CYP2A6 genotype, Δ8-THC could be a candidate for smoking cessation therapy. Significance Statement This study is the first, to the best of our knowledge, to identify Δ-8-tetrahydrocannabinol as a potent and irreversible inhibitor of nicotine metabolism to cotinine. The extent of inhibition is modulated by genetic variation in cytochrome P450 2A6. These findings suggest that further investigations focusing on Δ-8-tetrahydrocannabinol and its potential as a candidate for smoking cessation therapy are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Molecular Biosciences, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York.
- Division of Molecular Biosciences, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York. Electronic address: plazarus@buffalo.edu.
Förderung
- National Cancer Institute
- National Cancer Institute Division of Cancer Prevention
Zitieren
APA
Zhao, M., Luo, S., & Lazarus, P. (2026). Inhibitory effects of Δ8-tetrahydrocannabinol on nicotine metabolism and implications as a smoking cessation agent. Drug Metabolism and Disposition. https://doi.org/10.1016/j.dmd.2026.100235
Vancouver
Zhao M, Luo S, Lazarus P. Inhibitory effects of Δ8-tetrahydrocannabinol on nicotine metabolism and implications as a smoking cessation agent. Drug Metabolism and Disposition. 2026. doi:10.1016/j.dmd.2026.100235
BibTeX
@article{Zhao2026,
author = {Zhao, Mengqi and Luo, Shaman and Lazarus, Philip},
title = {Inhibitory effects of Δ8-tetrahydrocannabinol on nicotine metabolism and implications as a smoking cessation agent},
journal = {Drug Metabolism and Disposition},
year = {2026},
doi = {10.1016/j.dmd.2026.100235}
}
EUVIMED